Extension Study for 43USSA1705

Open Label Extension Study for 43USSA1705 (A Randomized, Evaluator-blinded, Multi-center Study to Evaluate the Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds)

To evaluate the long-term safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.

Inclusion Criteria:

• Randomized to Sculptra Aesthetic 8ml reconstitution and successfully completed study 43USSA1705

Exclusion Criteria:

• Medical condition that in the opinion of the Investigator would make the subject unsuitable for inclusion
• Other condition preventing the subject from entering the study in the Investigator's opinion
• Participation in any interventional clinical study throughout the duration of the study